$19.23
In chiusura: Oct 13 EDT
$19.23
0.000.00%
Pre-mercato: 4:00 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Seres Therapeutics Inc (NASDAQ:MCRB) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 936.25K a 858.37K. Questo rappresenta il 15.94% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Seres Therapeutics Corp (XNAS:MCRB) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 139.76K azioni scambiate al giorno, ci vorrebbero 6.14 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
858.37K
Vendite allo scoperto %
15.9%
Giorni di copertura
6.14
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
MCRB | Seres Therapeutics, Inc. Commo | 09/30/2025 | 10/09/2025 | 15.94% | 5,386,414 | 858,372 | 139,760 | 6.14 | |
MCRB | Seres Therapeutics, Inc. Commo | 09/15/2025 | 09/24/2025 | 17.38% | 5,386,414 | 936,245 | 378,634 | 2.47 | |
MCRB | Seres Therapeutics, Inc. Commo | 08/29/2025 | 09/10/2025 | 18.79% | 5,386,414 | 1,012,144 | 117,506 | 8.61 | |
MCRB | Seres Therapeutics, Inc. Commo | 08/15/2025 | 08/26/2025 | 19.20% | 5,386,414 | 1,034,377 | 122,470 | 8.45 | |
MCRB | Seres Therapeutics, Inc. Commo | 07/31/2025 | 08/11/2025 | 18.65% | 5,386,414 | 1,004,423 | 126,313 | 7.95 | |
MCRB | Seres Therapeutics, Inc. Commo | 07/15/2025 | 07/24/2025 | 16.05% | 5,364,266 | 861,106 | 175,216 | 4.91 | |
MCRB | Seres Therapeutics, Inc. Commo | 06/30/2025 | 07/10/2025 | 12.92% | 5,364,266 | 693,134 | 120,771 | 5.74 | |
MCRB | Seres Therapeutics, Inc. Commo | 06/13/2025 | 06/25/2025 | 12.67% | 5,364,266 | 679,397 | 81,335 | 8.35 | |
MCRB | Seres Therapeutics, Inc. Commo | 05/30/2025 | 06/10/2025 | 13.26% | 5,364,266 | 711,221 | 69,141 | 10.29 | |
MCRB | Seres Therapeutics, Inc. Commo | 05/15/2025 | 05/27/2025 | 14.89% | 5,364,266 | 798,969 | 108,120 | 7.39 | |
MCRB | Seres Therapeutics, Inc. Commo | 04/30/2025 | 05/09/2025 | 11.41% | 5,349,781 | 610,359 | 202,886 | 3.01 | |
MCRB | Seres Therapeutics, Inc. Commo | 04/15/2025 | 04/25/2025 | — | 5,349,781 | 15,262,138 | 1,276,585 | 11.96 | |
MCRB | Seres Therapeutics, Inc. Commo | 03/31/2025 | 04/09/2025 | 14.96% | 106,995,642 | 16,010,235 | 812,899 | 19.7 | |
MCRB | Seres Therapeutics, Inc. Commo | 03/14/2025 | 03/25/2025 | 15.63% | 106,995,642 | 16,718,590 | 908,601 | 18.4 | |
MCRB | Seres Therapeutics, Inc. Commo | 02/28/2025 | 03/11/2025 | 13.51% | 127,569,892 | 17,234,746 | 711,413 | 24.23 | |
MCRB | Seres Therapeutics, Inc. Commo | 02/14/2025 | 02/26/2025 | 13.87% | 127,569,892 | 17,694,032 | 784,322 | 22.56 | |
MCRB | Seres Therapeutics, Inc. Commo | 01/31/2025 | 02/11/2025 | 13.68% | 127,569,892 | 17,456,803 | 2,989,948 | 5.84 | |
MCRB | Seres Therapeutics, Inc. Commo | 01/15/2025 | 01/27/2025 | 15.88% | 127,569,892 | 20,261,193 | 1,298,346 | 15.61 | |
MCRB | Seres Therapeutics, Inc. Commo | 12/31/2024 | 01/10/2025 | 16.02% | 127,569,892 | 20,440,169 | 1,890,611 | 10.81 | |
MCRB | Seres Therapeutics, Inc. Commo | 12/13/2024 | 12/24/2024 | 15.37% | 127,569,892 | 19,613,483 | 3,038,507 | 6.45 | |
MCRB | Seres Therapeutics, Inc. Commo | 11/29/2024 | 12/10/2024 | 13.63% | 127,569,892 | 17,381,399 | 4,495,587 | 3.87 | |
MCRB | Seres Therapeutics, Inc. Commo | 11/15/2024 | 11/26/2024 | 12.73% | 127,569,892 | 16,235,306 | 2,512,081 | 6.46 | |
MCRB | Seres Therapeutics, Inc. Commo | 10/31/2024 | 11/11/2024 | 14.05% | 127,032,076 | 17,852,612 | 1,872,282 | 9.54 | |
MCRB | Seres Therapeutics, Inc. Commo | 10/15/2024 | 10/24/2024 | 14.21% | 127,032,076 | 18,054,013 | 3,957,489 | 4.56 | |
MCRB | Seres Therapeutics, Inc. Commo | 09/30/2024 | 10/09/2024 | 14.69% | 127,032,076 | 18,656,453 | 6,219,924 | 3 | |
MCRB | Seres Therapeutics, Inc. Commo | 09/13/2024 | 09/24/2024 | 15.76% | 109,213,562 | 17,215,115 | 5,850,328 | 2.94 | |
MCRB | Seres Therapeutics, Inc. Commo | 08/30/2024 | 09/11/2024 | 14.60% | 109,213,562 | 15,940,210 | 1,520,212 | 10.49 | |
MCRB | Seres Therapeutics, Inc. Commo | 07/31/2024 | 08/09/2024 | 15.12% | 108,249,112 | 16,362,258 | 4,477,804 | 3.65 | |
MCRB | Seres Therapeutics, Inc. Commo | 07/15/2024 | 07/24/2024 | 15.71% | 108,249,112 | 17,001,853 | 3,734,284 | 4.55 | |
MCRB | Seres Therapeutics, Inc. Commo | 06/28/2024 | 07/10/2024 | 19.11% | 108,249,112 | 20,686,202 | 3,336,807 | 6.2 | |
MCRB | Seres Therapeutics, Inc. Commo | 06/14/2024 | 06/26/2024 | 21.11% | 108,249,112 | 22,849,640 | 6,618,838 | 3.45 | |
MCRB | Seres Therapeutics, Inc. Commo | 05/31/2024 | 06/11/2024 | 20.87% | 108,249,112 | 22,596,209 | 2,131,124 | 10.6 | |
MCRB | Seres Therapeutics, Inc. Commo | 05/15/2024 | 05/24/2024 | 21.00% | 108,249,112 | 22,737,212 | 6,683,307 | 3.4 | |
MCRB | Seres Therapeutics, Inc. Commo | 04/30/2024 | 05/09/2024 | 19.83% | 108,249,112 | 21,462,357 | 5,832,690 | 3.68 | |
MCRB | Seres Therapeutics, Inc. Commo | 04/15/2024 | 04/24/2024 | 16.36% | 107,810,811 | 17,634,355 | 4,188,886 | 4.21 | |
MCRB | Seres Therapeutics, Inc. Commo | 03/28/2024 | 04/09/2024 | 17.44% | 107,810,811 | 18,803,257 | 3,023,809 | 6.22 | |
MCRB | Seres Therapeutics, Inc. Commo | 03/15/2024 | 03/26/2024 | 17.06% | 107,810,811 | 18,397,627 | 5,742,326 | 3.2 | |
MCRB | Seres Therapeutics, Inc. Commo | 02/29/2024 | 03/11/2024 | 14.94% | 107,810,811 | 16,104,377 | 3,939,656 | 4.09 | |
MCRB | Seres Therapeutics, Inc. Commo | 02/15/2024 | 02/27/2024 | 22.69% | 68,728,747 | 15,591,918 | 2,538,032 | 6.14 | |
MCRB | Seres Therapeutics, Inc. Commo | 01/31/2024 | 02/09/2024 | 22.68% | 68,728,747 | 15,590,248 | 4,144,008 | 3.76 | |
MCRB | Seres Therapeutics, Inc. Commo | 01/12/2024 | 01/24/2024 | 25.54% | 68,728,747 | 17,553,318 | 8,840,617 | 1.99 | |
MCRB | Seres Therapeutics, Inc. Commo | 12/29/2023 | 01/10/2024 | 23.68% | 68,728,747 | 16,277,554 | 4,138,787 | 3.93 | |
MCRB | Seres Therapeutics, Inc. Commo | 12/15/2023 | 12/27/2023 | 30.28% | 68,728,747 | 20,814,217 | 4,635,859 | 4.49 | |
MCRB | Seres Therapeutics, Inc. Commo | 11/30/2023 | 12/11/2023 | 30.49% | 68,728,747 | 20,953,327 | 3,702,243 | 5.66 | |
MCRB | Seres Therapeutics, Inc. Commo | 11/15/2023 | 11/27/2023 | 34.00% | 68,728,747 | 23,369,313 | 6,824,952 | 3.42 | |
MCRB | Seres Therapeutics, Inc. Commo | 10/31/2023 | 11/09/2023 | 33.62% | 68,728,747 | 23,104,830 | 3,011,984 | 7.67 | |
MCRB | Seres Therapeutics, Inc. Commo | 10/13/2023 | 10/24/2023 | 33.77% | 67,676,162 | 22,854,391 | 2,821,623 | 8.1 |
In cerca di azioni più vendute allo scoperto?